Log In
Print
BCIQ
Print
Print this Print this
 

ReS19-T

  Manage Alerts
Collapse Summary General Information
Company reMYND N.V.
DescriptionSmall molecule against an undisclosed target that prevents neurotoxicity associated with microtubule-associated protein tau
Molecular Target Microtubule-associated protein tau (MAPT) (tau) (FTDP-17)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationAlzheimer's disease (AD)
Partner

Roche
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today